2018
DOI: 10.1038/s41598-018-31372-y
|View full text |Cite
|
Sign up to set email alerts
|

Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells

Abstract: Steroid receptor coactivator-2 (SRC-2) is a transcriptional coregulator that modulates the activity of many transcription factors. Levels of SRC-2 are elevated in endometrial biopsies from polycystic ovary syndrome patients, a population predisposed to endometrial cancer (EC). Increased expression of SRC-2 is also detected in neoplastic endometrium suggesting a causal link between elevated SRC-2 expression and the emergence of endometrial disorders that can lead to cancer. Here, we reveal that SRC-2 knockdown … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 51 publications
(50 reference statements)
0
5
0
Order By: Relevance
“…The question is raised because SRC-2 (along with other SRC members) is an established coregulator of carbohydrate, lipid, and amino acid metabolism in other physiological systems ( Stashi et al, 2014 ; O’Malley, 2020 ). Furthermore, SRC-2 in human endometrial cancer cells was recently shown to be essential for the normal performance of the pentose phosphate pathway in addition to maintaining cellular glycolytic capacity and oxidative phosphorylation ( Szwarc et al, 2018b ). As an anabolic multi-enzyme pathway, the pentose phosphate pathway generates NADPH for reductive biosynthesis as well as pentoses (including ribose 5-phosphate) to generate nucleotides for DNA and RNA synthesis.…”
Section: Modifiers Of Pgr Mediated Responses In the Endometrial Epithmentioning
confidence: 99%
See 1 more Smart Citation
“…The question is raised because SRC-2 (along with other SRC members) is an established coregulator of carbohydrate, lipid, and amino acid metabolism in other physiological systems ( Stashi et al, 2014 ; O’Malley, 2020 ). Furthermore, SRC-2 in human endometrial cancer cells was recently shown to be essential for the normal performance of the pentose phosphate pathway in addition to maintaining cellular glycolytic capacity and oxidative phosphorylation ( Szwarc et al, 2018b ). As an anabolic multi-enzyme pathway, the pentose phosphate pathway generates NADPH for reductive biosynthesis as well as pentoses (including ribose 5-phosphate) to generate nucleotides for DNA and RNA synthesis.…”
Section: Modifiers Of Pgr Mediated Responses In the Endometrial Epithmentioning
confidence: 99%
“…As an anabolic multi-enzyme pathway, the pentose phosphate pathway generates NADPH for reductive biosynthesis as well as pentoses (including ribose 5-phosphate) to generate nucleotides for DNA and RNA synthesis. Together, these SRC-2 dependent pathways are required to drive rapid proliferation and anchorage independent growth of this cancer cell type ( Szwarc et al, 2018b ). Whether SRC-2 is also required for pentose phosphate pathway functionality in normal human endometrial cells awaits investigation; (2) Is impaired control of the glycolytic pathway an underpinning for the implicated role of SRC-2 in endometrial pathologies as observed in patients with polycystic ovary syndrome or endometrial cancer?…”
Section: Modifiers Of Pgr Mediated Responses In the Endometrial Epithmentioning
confidence: 99%
“…Using the timed natural pregnancy model, we reveal here that SRC‐2 is pivotal for the PMT changes that must occur in the luminal epithelium to enable embryo attachment and adherence within the context of a receptive uterus. Given the cell‐type specific roles of SRC‐2 in endometrial biology and pathobiology 10,19,20,25,83,84 and the knowledge‐gap associated with early pregnancy establishment, our findings provide a foundation for further investigations into the specific involvement of this coregulator in the endometrial epithelium in ensuring normal endometrial function and health.…”
Section: Discussionmentioning
confidence: 88%
“…Kras promotes glycolysis intermediates and non-oxidative PPP in pancreatic tumors, and blocking the non-oxidative PPP by the knockdown of RPIA or RPE in the tumor cells inhibits tumor growth [ 14 ]. In addition, RPIA is involved in liver cancer [ 15 , 16 ], colorectal cancer [ 17 , 18 ] and endometrial cancer [ 19 ]. However, the role of RPIA in lung cancer remains unclear.…”
Section: Introductionmentioning
confidence: 99%